4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors.

[1]  T. Kanazawa,et al.  Discovery of selective and nonpeptidic cathepsin S inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[2]  B. Maryanoff,et al.  Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. , 2008, Bioorganic & medicinal chemistry.

[3]  A. Ray,et al.  Cysteine cathepsin S as an immunomodulatory target: present and future trends , 2008, Expert opinion on therapeutic targets.

[4]  O. Ohmori,et al.  Novel scaffold for cathepsin K inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[5]  Wen Jiang,et al.  Pyrazole-based cathepsin S inhibitors with improved cellular potency. , 2007, Bioorganic & medicinal chemistry letters.

[6]  M. Percival,et al.  The identification of potent, selective, and bioavailable cathepsin S inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[7]  S. Bevan,et al.  Role of the cysteine protease cathepsin S in neuropathic hyperalgesia , 2007, PAIN.

[8]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[9]  Jennifer L. Harris,et al.  Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S. , 2007, Bioorganic & medicinal chemistry letters.

[10]  M. Hao,et al.  Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[11]  G. Spraggon,et al.  Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode. , 2007, Journal of medicinal chemistry.

[12]  E. Altmann,et al.  2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K. , 2007, Journal of medicinal chemistry.

[13]  P. Janser,et al.  A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors. , 2006, Bioorganic & Medicinal Chemistry Letters.

[14]  K. Nakano,et al.  Design of an organocatalyst for the enantioselective Diels-Alder reaction with alpha-acyloxyacroleins. , 2005, Journal of the American Chemical Society.

[15]  Ronald E White,et al.  Whatever happened to cassette-dosing pharmacokinetics? , 2004, Drug discovery today.

[16]  Traian Sulea,et al.  Specificity determinants of human cathepsin s revealed by crystal structures of complexes. , 2003, Biochemistry.

[17]  E. Purisima,et al.  Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides. , 2002, Journal of medicinal chemistry.

[18]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.